Global Payments
GPN
81.08
-0.71
-0.87%
Global Payments
US · GPN
#873 by market cap
Listed 1970
81.08
-0.71
-0.87%
Live - 5344 symbols - heartbeat 456s ago
· 2026-10-08 07:35
Pre-market
81.08
0.00%
After-hours
81.00
-0.10%
- Market cap
- 21.46B
- P/E (TTM)i
- -26.76
- P/Bi
- 0.93
- EPSi
- 5.78
- Div yieldi
- 1.23%
- 52W posi
- 58%
Reader sentiment
Are you bullish or bearish on GPN?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Weak
- Altman Z-Score is 0.94, below the 1.8 "distress zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year -0.39% YoY
Margins
- Gross margin
- 72.57%
- Operating margin
- 19.10%
- Net margin
- 18.17%
Key ratios & quality
- Enterprise valuei
- 34.98B
- Altman Z-Scorei
- 0.94
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 3.37B | 4.91B | 7.42B | 8.52B | 8.98B | 7.38B | 7.74B | 7.71B |
| Gross profit | 2.27B | 2.84B | 3.77B | 4.75B | 5.20B | 5.31B | 5.70B | 5.59B |
| Selling & admin expenses | 1.53B | 2.05B | 2.88B | 3.39B | 3.52B | 3.86B | 4.00B | 4.12B |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 737.06M | 791.42M | 893.95M | 1.36B | 1.67B | 1.45B | 1.70B | 1.47B |
| Pretax profit | 562.16M | 517.93M | 593.96M | 1.04B | 224.32M | 781.66M | 1.53B | 1.26B |
| Tax | 77.49M | 62.19M | 77.15M | 169.03M | 166.69M | 186.52M | 241.51M | 251.56M |
| Net profit | 484.67M | 469.28M | 605.10M | 987.86M | 143.31M | 1.03B | 1.64B | 1.46B |
| Basic EPS | 3 | 2 | 2 | 3 | 0 | 4 | 6 | 6 |
| Diluted EPS | 2.84 | 2.16 | 1.95 | 3.29 | 0.40 | 3.77 | 6.16 | 5.78 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 1.82B | 1.97B | 2.01B | 1.93B | 2.97B | 3.32B |
| Gross profit | 1.33B | 1.47B | 1.45B | 1.36B | 1.70B | 2.03B |
| Selling & admin expenses | 957.18M | 1.04B | 1.02B | 1.13B | 1.71B | 1.69B |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 367.97M | 426.26M | 434.12M | 234.70M | -15.65M | 337.12M |
| Pretax profit | 261.46M | 276.30M | 655.71M | 23.95M | -224.50M | 104.28M |
| Tax | 43.77M | 40.88M | 199.31M | -111.02M | -11.84M | -4.93M |
| Net profit | 312.77M | 246.10M | 660.60M | 236.58M | -1.78B | 28.92M |
| Basic EPS | 1 | 1 | 3 | 1 | -7 | 0 |
| Diluted EPS | 1.24 | 0.99 | 2.64 | 0.92 | -6.59 | 0.05 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 3.38B | 4.37B | 4.59B | 4.71B | 6.31B | 8.07B | 6.03B | 12.60B |
| Cash & ST investments | 1.21B | 1.68B | 1.95B | 1.98B | 2.00B | 2.09B | 2.36B | 8.34B |
| Inventory | -- | -- | -- | -- | -- | -- | -- | -- |
| Total assets | 13.23B | 44.48B | 44.20B | 45.28B | 44.81B | 50.57B | 46.89B | 53.34B |
| Total current liabilities | 3.27B | 3.58B | 4.55B | 4.46B | 6.90B | 8.13B | 6.25B | 7.46B |
| Short-term debt | 815.56M | 587.19M | 1.29B | 666.26M | 2.00B | 1.68B | 1.58B | 2.32B |
| Long-term debt | 5.02B | 9.09B | 8.47B | 11.41B | 12.29B | 15.69B | 15.08B | 19.54B |
| Total liabilities | 9,044,431,000.00 | 16,425,173,000.00 | 16,714,501,000.00 | 19,410,296,000.00 | 22,268,804,000.00 | 26,782,671,000.00 | 23,873,688,000.00 | 29,559,003,000.00 |
| Total equity | 4.19B | 28.05B | 27.49B | 25.87B | 22.54B | 23.79B | 23.02B | 23.78B |
| Retained earnings | 2.07B | 2.33B | 2.57B | 2.98B | 2.73B | 3.46B | 4.77B | 5.94B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 6.74B | 7.75B | 7.21B | 12.60B | 11.67B | 11.67B |
| Cash & ST investments | 2.90B | 2.61B | 2.60B | 8.34B | 5.86B | 5.41B |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | 47.62B | 48.52B | 47.96B | 53.34B | 64.25B | 63.57B |
| Total current liabilities | 7.14B | 8.18B | 8.43B | 7.46B | 14.75B | 14.15B |
| Short-term debt | 1.91B | 2.50B | 2.88B | 2.32B | 2.59B | 2.06B |
| Long-term debt | 15.01B | 14.15B | 13.32B | 19.54B | 20.98B | 21.49B |
| Total liabilities | 24,591,533,000.00 | 25,096,921,000.00 | 24,464,582,000.00 | 29,559,003,000.00 | 39,580,260,000.00 | 39,604,137,000.00 |
| Total equity | 23.02B | 23.42B | 23.50B | 23.78B | 24.67B | 23.97B |
| Retained earnings | 5.02B | 5.20B | 5.78B | 5.94B | 4.07B | 4.01B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 1.11B | 1.39B | 2.31B | 2.78B | 2.24B | 2.55B | 3.06B | 2.66B |
| Depreciation & amortization | 522.81M | 878.34M | 1.61B | 1.69B | 1.66B | 1.78B | 1.86B | 1.42B |
| Free cash flow | 892.79M | 1.08B | 1.88B | 2.29B | 1.63B | 1.89B | 2.38B | 2.04B |
| Dividends paid | -6.33M | -86.74M | -233.22M | -259.73M | -273.96M | -260.43M | -252.81M | -238.52M |
| Stock buybacks / issuance | -208.20M | -311.38M | -631.15M | -2.62B | -2.96B | -459.50M | -1.61B | -1.23B |
| Ending cash balance | 1.21B | 1.68B | 2.09B | 2.12B | 2.22B | 2.26B | 2.74B | 9.12B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 555.12M | 817.53M | 768.73M | 515.21M | -288.82M | 662.62M |
| Depreciation & amortization | 452.11M | 324.07M | 303.18M | 336.02M | 864.76M | 884.05M |
| Free cash flow | 427.55M | 665.36M | 598.92M | 347.00M | -550.16M | 426.96M |
| Dividends paid | -61.12M | -60.38M | -57.96M | -59.06M | -68.25M | -66.47M |
| Stock buybacks / issuance | -446.29M | -282.18M | -462.63M | -39.57M | -549.93M | -583.81M |
| Ending cash balance | 3.15B | 3.34B | 3.04B | 9.12B | 6.12B | 5.69B |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 11.61 | 2.70 | 2.12 | 3.65 | 0.47 | 4.35 | 6.94 | 6.20 |
| ROA %i | 3.45 | 1.49 | 1.32 | 2.16 | 0.25 | 2.07 | 3.22 | 2.79 |
| ROIC %i | 6.38 | 2.84 | 2.27 | 3.29 | 1.18 | 3.73 | 4.94 | 4.28 |
| 5-year avg ROE %i | -- | -- | -- | 6.93 | 4.11 | 2.66 | 3.50 | 4.32 |
| EBIT margin %i | 22.51 | 16.75 | 12.63 | 16.17 | 7.51 | 18.96 | 24.77 | 24.78 |
| FCF / sales %i | 26.52 | 22.06 | 25.30 | 26.84 | 18.14 | 16.48 | 28.28 | 26.46 |
| Current ratioi | 1.03 | 1.22 | 1.01 | 1.06 | 0.92 | 0.99 | 0.96 | 1.69 |
| Quick ratioi | 0.48 | 0.72 | 0.60 | 0.66 | 0.43 | 0.39 | 0.50 | 1.22 |
| Debt / assetsi | 44.07 | 21.76 | 22.07 | 26.68 | 31.88 | 34.36 | 35.53 | 40.99 |
| LT debt / equityi | 125.65 | 32.63 | 30.98 | 44.54 | 55.10 | 68.23 | 67.68 | 85.38 |
| Interest coveragei | 3.87 | 2.70 | 2.73 | 4.13 | 1.50 | 2.77 | 3.95 | 2.94 |
| Revenue CAGR (3Y) %i | 5.54 | 15.85 | 23.15 | 36.30 | 22.26 | -0.20 | -3.18 | -4.96 |
| Net income CAGR (3Y) %i | 14.50 | 13.71 | 7.66 | 28.78 | -36.26 | 19.05 | 17.60 | 132.44 |
| FCF CAGR (3Y) %i | 31.15 | 23.97 | 78.45 | 36.84 | 14.55 | 0.24 | 1.37 | 7.78 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 7.03 | 6.36 | 7.69 | 6.20 | -3.06 | -4.09 |
| ROA %i | 3.14 | 2.88 | 3.57 | 2.79 | -1.26 | -1.67 |
| ROIC %i | 4.87 | 4.49 | 5.34 | 4.28 | -0.61 | -0.94 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 25.00 | 24.63 | 27.61 | 24.78 | 17.14 | 14.41 |
| FCF / sales %i | 28.73 | 29.18 | 28.45 | 26.46 | 11.98 | 8.06 |
| Current ratioi | 0.94 | 0.95 | 0.85 | 1.69 | 0.79 | 0.82 |
| Quick ratioi | 0.56 | 0.42 | 0.41 | 1.22 | 0.49 | 0.49 |
| Debt / assetsi | 35.54 | 34.31 | 33.78 | 40.99 | 36.69 | 37.05 |
| LT debt / equityi | 67.49 | 62.63 | 58.77 | 85.38 | 88.20 | 93.00 |
| Interest coveragei | 4.01 | 3.92 | 4.44 | 2.94 | 2.04 | 1.69 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Small and Medium-Sized Businesses (SMB) is the largest reported line at 49.66% of revenue, across 4 reported segments.
- Enterprise follows at 25.24%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Small and Medium-Sized Businesses (SMB)49.66%
Enterprise25.24%
Platforms19.66%
Other revenues5.44%
Quote time 2026-10-08 07:35:46 · For reference only, not investment advice and not tailored to your situation.